🔎 Trials Near Me

Home › Mantle Cell Lymphoma › Ohio › Columbus

Mantle Cell Lymphoma clinical trials in Columbus, OH

11 studies for Mantle Cell Lymphoma are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

RecruitingPhase 3
  • Ohio State University Comprehensive Cancer Center, Columbus
Ages 60 and older · All sexes · Updated Oct 2, 2026 · NCT05976763

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

RecruitingPhase 3
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Ohio Health Research Institute, Columbus
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06742996

Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy

RecruitingPhase 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07003295

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

RecruitingPhase 1/2
  • Research Site, Columbus
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06564038

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

RecruitingPhase 1/2
  • The Ohio State University Wexner Medical Center, Columbus
Ages 13 to 90 · All sexes · Updated Aug 6, 2026 · NCT06533579

DALY II USA/ MB-CART2019.1 for DLBCL

RecruitingPhase 2
  • The Ohio State University Wexner Medical Center James Cancer, Columbus
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT04792489

Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

RecruitingPhase 1/2
  • The Ohio State University Comprehensive Cancer Center, Columbus
Ages 18 and older · All sexes · Updated Apr 22, 2026 · NCT03523975

Study of SGR-1505 in Mature B-Cell Neoplasms

RecruitingPhase 1
  • The Ohio State University - The James Cancer Hospital, Columbus
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT05544019

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

RecruitingPhase 1
  • Ohio State University, Columbus
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT04775745

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Columbus
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

RecruitingPhase 1
  • The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus
Ages 18 and older · All sexes · Updated Oct 2, 2025 · NCT05780034

Mantle Cell Lymphoma trials in other cities

Other studies in Columbus

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.